An assessment of expert members of panels making decisions about definitions or diagnostic criteria for common conditions in the US, which were published in guidelines used by physicians and other healthcare professionals ...
Aug 13, 2013
0
0
(HealthDay)—Experts selected by the food industry have often been the ones approving the safety of food additives for the past 15 years, a new report claims.
Aug 7, 2013
0
0
A Japanese university Wednesday said it would retract a study that touted the effectiveness of a blood pressure drug made by Swiss pharmaceutical giant Novartis because it was based on fabricated data.
Jul 31, 2013
0
0
(HealthDay)—Abstracts submitted to the American Society of Clinical Oncology (ASCO) annual meeting by researchers who have financial relationships with commercial interests are more prominently placed and more favorably ...
Jun 25, 2013
0
0
In an age when evidence-based care is increasingly important, how trustworthy are current clinical practice guidelines?
Jun 12, 2013
0
0
A 2012 law that loosened conflict-of-interest restrictions for FDA advisory panels could weaken the agency's review system and could allow more drugs with safety problems to gain market approval, says a new analysis published ...
Jun 6, 2013
4
0
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
May 20, 2013
0
0
(HealthDay)—As part of the National Physician Payment Transparency Program and in compliance with a provision in the Affordable Care Act (ACA), the government will make information about financial relationships between ...
May 2, 2013
0
0
(HealthDay)—At the 2011 American Academy of Orthopaedic Surgeons (AAOS) annual meeting, voluntarily disclosed conflicts of interest were common, especially for featured symposia, according to a study published in the March ...
Mar 19, 2013
0
0
An analysis of policy documents from Medicaid programs, suggests that current policies to manage conflicts of interest (COIs) of members of Medicaid drug selection committees are not transparent and vary widely, according ...
Feb 11, 2013
0
0
